Fentanilo Zentiva

Fentanilo Zentiva is a transdermal patch containing fentanyl, used for managing chronic pain. This medication is manufactured by Zentiva Portugal, Lda and is available in the EU market.

Fentanilo Zentiva is primarily used for the management of chronic pain that requires around-the-clock opioid analgesia. It is often prescribed for patients who have developed a tolerance to other pain medications. The transdermal patch delivers fentanyl through the skin, providing a steady release of the medication over time. This method of administration is designed to help maintain consistent pain relief.

Common effects of Fentanilo Zentiva may include drowsiness, dizziness, nausea, and constipation. Some users may also experience itching or redness at the application site. These effects can vary from person to person and may subside as the body adjusts to the medication.

Fentanilo Zentiva should be handled with care, especially when applying or removing the patch. It is important to follow the instructions provided by your healthcare professional to ensure proper use. The patch should be applied to a clean, dry area of skin and should not be exposed to heat or direct sunlight, as this can increase the amount of medication absorbed.

Fentanilo Zentiva may interact with other medications, including other opioids, sedatives, and alcohol. It is important to inform your healthcare professional about all medications you are taking to avoid potential interactions. Combining fentanyl with other central nervous system depressants can increase the risk of severe side effects.